Key result
Oral anticoagulation currently treats over 2 million people in North America, a population expected to grow as the incidence of conditions like atrial fibrillation increases.
Discusses the management of periprocedural anticoagulation in the growing population of chronically anticoagulated patients.
M ore than 2 million people are currently treated with oral anticoagulation in North America alone.1 Indeed, chronically anticoagulated patients are expected to become more prevalent as the population ages and the incidence of conditions (for example, atrial fibrillation) requiring anticoagulation increases.2
No takes yet. Share an insight, caveat, or question.
Gallego et al. (2012) studied this question. Oral anticoagulation currently treats over 2 million people in North America, a population expected to grow as the incidence of conditions like atrial fibrillation increases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: